Medifast is a leader in dietary weight management that fell off a cliff since 2022 due to inflationary pressures, the re-opening of restaurants, and the rise of GLP-1 drugs. The company's turnaround ...
11monon MSN
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions
Q4 2024 Management View CEO Dan Chard highlighted that 2024 was a transformative year for Medifast due to the increasing adoption of GLP-1 weight loss medications. The company is adapting to these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results